4.480USD-4.38%Mkt Cap: 318.10M USDP/E: 15.84Last update: 2026-06-01
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security market in the United States. The company's lead product is TPOXX, an antiviral drug for the treatment of human smallpox d…
Industry Peers
Drug Manufacturers - Specialty & GenericIndicators:|
Key Statistics
Company
Market Cap318.10M USD
Enterprise Value190.71M USD
Revenue (TTM)93.78M USD
Gross Profit64.87M USD
Net Income (TTM)23.28M USD
Revenue/Share1.310 USD
Last Price4.480 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees49
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN—
Valuation
P/E (Trailing)15.84
P/E (Forward)4.46
PEG3.37
EV/EBITDA8.99
EV/Revenue2.03
P/S3.58
P/B1.69
EPS (TTM)0.28
EPS (Forward)1.05
52W Range
4.1007% of range9.620
52W High9.620 USD
52W Low4.100 USD
Profitability
Gross Margin68.59%
Oper. Margin-85.24%
EBITDA Margin22.62%
Profit Margin24.61%
ROE11.71%
ROA10.61%
Growth
Revenue Growth-11.30%
Earnings Growth—
Cash Flow & Leverage
Operating CF43.47M USD
CapEx (TTM)355.01K USD
FCF Margin63.39%
FCF Yield18.69%
Net Debt-144.96M USD
Net Debt/EBITDA-6.83
Balance Sheet
Debt/Equity0.00
Current Ratio3.25
Quick Ratio2.30
Book Value/Sh2.776 USD
Cash/Share2.029 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div DateApr 7, 2026
Pay DateApr 23, 2026
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.71.72M
Float41.12M
Insiders42.66%
Institutions49.97%
Short Interest
Short Ratio6.9d
Short % Float7.14%
Short % Out.4.62%
Shares Short3.31M
Short (prev mo.)3.24M
Technical
SMA 504.692 (-4.5%)
SMA 2006.613 (-32.3%)
Beta0.85
S&P 52W Chg27.70%
Avg Vol (30d)469.89K
Avg Vol (10d)558.76K
Technical Indicators
RSI (14)52.8
MACD-0.0131
MACD Signal-0.0665
MACD Hist.+0.0534
BB Upper4.941 USD
BB Middle4.560 USD
BB Lower4.179 USD
BB Width16.71%
ATR (14)0.1732 USD
Vol Ratio (20d)0.38x